Combinatorial
Locksmith
(continued)
"The Arizona
Cancer Center is well-established," said Lam, who achieved
great success in the research arena while there. "But I was
ready for the opportunity to return to California and contribute
to the building of this program. There is strong support for the
cancer program here. It's obvious this is an up-and-coming program,
and I believe I can make a contribution here."
He's not alone.
"The synergy
between his work and that of other researchers here, such as Hsing-Jien
Kung, who works on signal transduction, and David Gandara, who works
on developmental therapeutics, has great potential," said deVere
White, who is heading the cancer center's full-court press to achieve
National Cancer Institute designation.
"His work
dovetails beautifully with theirs so the sum of the parts is greater
than any of the parts individually."
Already Lam
has struck up working relationships with UC Davis radioimmunotherapy
researchers Robert O'Donnell, Gerald and Sally DeNardo and chemist
Claude Meares to use the process of combinatorial chemistry to develop
peptides that target lymphoma and ovarian cancer cells.
Home |
Table of Contents |
To our Readers |
Building on Basics
Focusing on Patients |
In Translation |
First Steps
Campus Connection |
Benefactors |
News in Brief
UC Davis Health System |
© 2000, 2001, 2002 UC Regents. All rights reserved.
|
|
This
container holds one combinatorial library containing approximately
four million peptide compounds.
|